Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations.
BACKGROUND
Little is known about the enteric protein loss in patients after a modified Fontan operation before the appearance of overt symptoms or signs of protein-losing enteropathy (PLE). The authors examined the possibility of using fecal alpha1-antitrypsin concentration measurements for the early detection of postoperative PLE and in longer term postoperative monitoring of these patients.


METHODS
The authors compared fecal alpha1-antitrypsin concentrations in stool samples from 12 children 12.0 to 43.7 months after modified Fontan operations with those of 12 age-matched control subjects and examined the relationship between the alpha1-antitrypsin levels and time since operation. The authors also compared fecal alpha1-antitrypsin concentrations of stools from the same patients obtained at two different time points after surgery with intervals between samples ranging from 14.7 to 19.8 months.


RESULTS
No significant differences in serum total protein and albumin levels were observed between patients after the modified Fontan operation and control subjects. The fecal concentrations of alpha1-antitrypsin in patients after the Fontan operation were significantly (P < 0.01) higher than those in control subjects. There was no significant correlation between fecal alpha1-antitrypsin concentrations and time elapsed after the Fontan operation. The fecal alpha1-antitrypsin concentration increased significantly (P < 0.01) over periods of 14.7 to 19.8 months after the first measurement.


CONCLUSIONS
The results show that enteric protein loss begins before the appearance of hypoproteinemia in patients after a modified Fontan operation, and that the measurement of fecal alpha1-antitrypsin concentrations in random stool samples is useful as an early indicator. To watch for the development of PLE after Fontan operation, it may be important to perform longitudinal follow-up examinations of enteric protein loss by measuring fecal alpha1-antitrypsin concentrations early in the postoperative period.
Fujii
Tohru
T
Department of Pediatrics, Juntendo University, School of Medicine, Tokyo, Japan.
Shimizu
Toshiaki
T
Takahashi
Ken
K
Kishiro
Masahiko
M
Ohkubo
Mataichi
M
Akimoto
Katsumi
K
Yamashiro
Yuichiro
Y
D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005243:Feces / Q000737:chemistry*; D005260:Female; D018729:Fontan Procedure / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011504:Protein-Losing Enteropathies / Q000175:diagnosis* / Q000209:etiology; D012709:Serum Albumin / Q000032:analysis; D013997:Time Factors; D000515:alpha 1-Antitrypsin / Q000032:analysis*
D001798:Blood Proteins; D012709:Serum Albumin; D000515:alpha 1-Antitrypsin